BRIEF published on 06/14/2024 at 22:50, 1 year 7 months ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase® Shareholders Theralase® Virtual Meeting AGSM Zoom Presentation
BRIEF published on 06/14/2024 at 22:50, 1 year 7 months ago Avis de rappel d'assemblée générale annuelle et extraordinaire des actionnaires de Theralase® Actionnaires Theralase® Réunion Virtuelle AGSM Présentation Zoom
PRESS RELEASE published on 06/14/2024 at 22:45, 1 year 7 months ago Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R) Theralase Technologies Inc. provides a reminder for its Annual General and Special Meeting to be held on June 19th, 2024, with a virtual Zoom presentation including a Q&A session for shareholders Annual General Meeting Shareholders Theralase Technologies Inc. AGSM Virtual Zoom Presentation
BRIEF published on 06/12/2024 at 13:05, 1 year 7 months ago Rutherrin® Increases Efficacy of Chemotherapy Cancer Treatment Chemotherapy Rutherrin® Multidrug Resistance Theralase® Technologies
BRIEF published on 06/12/2024 at 13:05, 1 year 7 months ago Rutherrin® augmente l'efficacité de la chimiothérapie Traitement Du Cancer Chimiothérapie Rutherrin® Résistance Multidrogue Technologies Theralase®
PRESS RELEASE published on 06/12/2024 at 13:00, 1 year 7 months ago Rutherrin(R) Increases Efficacy of Chemotherapy Theralase Technologies announces preclinical success of Rutherrin® in enhancing chemotherapy efficacy and reducing multidrug resistance in cancer cells Cancer Treatment Theralase Technologies Rutherrin® Multidrug Resistance Chemotherapy Efficacy
BRIEF published on 06/10/2024 at 13:05, 1 year 8 months ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Cancer Treatment Theralase Technologies Ruvidar(TM) BCG NMIBC
BRIEF published on 06/10/2024 at 13:05, 1 year 8 months ago Ruvidar(TM) améliore l'efficacité d'un médicament contre le cancer Traitement Du Cancer Technologies Théralase Ruvidar(TM) BCG NMIBC
PRESS RELEASE published on 06/10/2024 at 13:00, 1 year 8 months ago Ruvidar(TM) Enhances Efficacy of Cancer Drug Theralase® Technologies Inc. announces breakthrough in cancer research by developing RuBCG compound to enhance efficacy of bladder cancer treatment. Preclinical results show promising potential Theralase Technologies Inc. Cancer Research RuBCG Compound Bladder Cancer Treatment Preclinical Results
BRIEF published on 06/06/2024 at 13:05, 1 year 8 months ago Theralase Successfully Destroys Lung Cancer Preclinical Study Theralase Technologies Lung Cancer Rutherrin®
Published on 02/11/2026 at 23:00, 28 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update On MCTO
Published on 02/11/2026 at 23:00, 28 minutes ago FutureGen Industries Announces Closing of Private Placement
Published on 02/11/2026 at 22:30, 58 minutes ago Battery X Metals Announces Strategic Sale of Gold & Copper Project Consistent with Its 360° Battery Metals Value Chain Strategy Encompassing Exploration, Rebalancing and Recycling in Support of the Energy Transition
Published on 02/11/2026 at 22:30, 58 minutes ago Green Bridge Metals Announces Partnership with APEX to Support Regional Engagement in Minnesota
Published on 02/11/2026 at 22:30, 58 minutes ago Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
Published on 02/11/2026 at 19:52, 3 hours 35 minutes ago LR Health & Beauty SE lays foundation for positive future business performance with new financing structure
Published on 02/11/2026 at 19:50, 3 hours 37 minutes ago EQS-Adhoc: LR HEALTH & BEAUTY SE REACHES AN AGREEMENT WITH BONDHOLDERS AND SHAREHOLDER REGARDING A COMPREHENSIVE RESTRUCTURING OF THE 2024/2028 BOND – EUR 20 MILLION IN NEW CAPITAL AND ...
Published on 02/11/2026 at 18:31, 4 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/11/2026 at 18:00, 5 hours 27 minutes ago Private Equity Holding AG: Net Asset Value as of January 31, 2026
Published on 02/11/2026 at 17:45, 5 hours 43 minutes ago Infotel : Stake held in AeroEx. A publisher of digital compliance and safety solutions for the aerospace industry.
Published on 02/11/2026 at 17:45, 5 hours 43 minutes ago Infotel : Prise de participation dans AeroEx éditeur de solutions digitales de conformité et de sécurité pour l’industrie aéronautique.
Published on 02/11/2026 at 11:25, 12 hours 2 minutes ago Innelec : Mise à disposition du rapport financier semestriel 2025-26
Published on 02/11/2026 at 08:00, 15 hours 28 minutes ago Imerys-press-release French State acquisition stake Emili Lithium
Published on 02/11/2026 at 08:00, 15 hours 28 minutes ago Imerys-communique-de-presse prise participation Etat Français Projet lithium Emili
